
OpenAI Researcher Miles Wang in Talks to Launch AI Drug Discovery Startup Valued at $2B
OpenAI researcher Miles Wang is in funding talks for a new AI drug discovery startup, with discussions valuing the company at $2 billion. The move underscores surging investor interest in applying AI to accelerate life-saving drug development.

